OR WAIT null SECS
September 02, 2020
AstraZeneca has potentially taken poll position in the race to develop a novel coronavirus vaccine, but will AZD1222 be ready in 2020?
The guidance recommends steps to detect and prevent nitrosamine impurities in pharmaceutical products.
The agency is reviewing an application for Dexamethasone Taw for treating adult patients with COVID-19.
The agency sent a warning letter to Acella Pharmaceuticals detailing CGMP violations and failures to oversee contract manufacturers.
The agency sent a warning letter after an inspection of the company’s Sangareddy District, India found inadequate cleaning procedures.
August 31, 2020
Hahn promises transparency in the review and approval of COVID-19 vaccines.
August 28, 2020
The company has appointed Liam Tayler as CEO to guide the growth of the company’s iPSC technologies, products, and services.
August 26, 2020
Merck’s anti-PD-1 therapy, Keytruda, has received two new approvals from the Japan Pharmaceuticals and Medical Devices Agency.
The European Commission (EC) and Moderna have concluded exploratory talks on the potential purchase of Moderna’s COVID-19 vaccine candidate for Europeans.
August 24, 2020
FDA issued an emergency use authorization for COVID-19 convalescent plasma treatments following a report on NIH concerns about insufficient studies and data.